av/odonate-therapeutics--big.svg

NASDAQ:ODT

Odonate Therapeutics, Inc.

  • Stock

USD

Last Close

1.17

01/01 00:00

Volume Today

716.44K

Avg: 959.82K

PE Ratio

−0.29

PFCF: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
average inventory
average payables
300.50K
-
2.44M
710.98%
7.54M
209.38%
13.18M
74.81%
14.88M
12.86%
average receivables
book value per share
0.00
-
0.08
1,956.76%
13.83
16,191.21%
5.07
63.35%
5.88
15.90%
4.15
29.40%
capex per share
-0.01
-
-0.08
1,230.85%
-0.01
92.29%
-0.01
119.04%
capex to depreciation
-4.15
-
-5.45
31.29%
-0.44
92.00%
-0.97
122.81%
capex to operating cash flow
0.00
-
0.03
785.49%
0.00
93.96%
0.00
122.30%
capex to revenue
cash per share
0.01
-
0.10
1,783.33%
13.98
14,365.46%
5.68
59.34%
6.53
14.92%
4.79
26.65%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.21
-
0.21
0.20%
0.04
82.22%
0.13
254.47%
0.14
7.36%
0.19
34.58%
debt to equity
0.26
-
0.26
0.26%
0.04
85.37%
0.15
292.78%
0.16
8.56%
0.23
42.64%
dividend yield
0.00
-
earnings yield
-0.00
-
-0.00
1,852.53%
-0.09
1,753.14%
-0.26
179.42%
-0.12
51.70%
-0.20
60.73%
enterprise value
618.34M
-
615.88M
0.40%
156.13M
74.65%
205.38M
31.54%
718.05M
249.62%
478.24M
33.40%
enterprise value over ebitda
-3.91K
-
-199.64
94.90%
-4.77
97.61%
-2.32
51.42%
-6.44
177.99%
-3.80
41.05%
ev to operating cash flow
-3.75K
-
-355.38
90.52%
-6.04
98.30%
-3.06
49.30%
-7.43
142.74%
-4.23
43.11%
ev to sales
free cash flow per share
-0.01
-
-0.06
950.30%
-1.83
2,740.74%
-2.82
54.07%
-3.50
24.23%
-3.46
1.26%
free cash flow yield
-0.00
-
-0.00
950.30%
-0.07
2,513.48%
-0.20
173.57%
-0.11
46.10%
-0.18
66.88%
graham net net
0.00
-
0.07
1,735.78%
13.45
17,976.03%
4.92
63.41%
5.57
13.23%
3.82
31.37%
graham number
0.02
-
0.47
1,903.97%
26.82
5,628.44%
20.37
24.06%
23.13
13.58%
18.95
18.06%
income quality
1.04
-
0.56
46.21%
0.79
40.58%
0.75
4.50%
0.86
14.58%
0.90
3.61%
intangibles to total assets
0
-
0
0
0
0
0
interest coverage
interest debt per share
0.02
-
inventory turnover
invested capital
0.00
-
market cap
618.48M
-
618.48M
0%
354.24M
42.72%
344.43M
2.77%
896.45M
160.27%
630.18M
29.70%
net current asset value
111K
-
2.27M
1,944.14%
195.43M
8,513.22%
121.13M
38.02%
157.40M
29.94%
128.13M
18.60%
net debt to ebitda
0.87
-
0.84
3.54%
6.05
618.58%
1.57
74.08%
1.60
2.01%
1.21
24.61%
net income per share
-0.01
-
-0.11
1,852.53%
-2.31
1,914.28%
-3.64
57.37%
-4.05
11.31%
-3.85
4.90%
operating cash flow per share
-0.01
-
-0.06
950.30%
-1.82
2,731.65%
-2.74
50.30%
-3.50
27.54%
-3.45
1.47%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-1.13
-
-1.07
5.12%
-0.16
84.97%
-0.62
287.50%
-0.59
5.02%
-0.75
27.08%
revenue per share
roe
-1.42
-
-1.35
5.07%
-0.17
87.64%
-0.72
329.38%
-0.69
3.96%
-0.93
34.70%
roic
0.96
-
1.07
11.52%
0.17
84.44%
0.62
273.53%
0.61
1.36%
0.79
29.40%
sales general and administrative to revenue
shareholders equity per share
0.00
-
0.08
1,956.76%
13.83
16,191.21%
5.07
63.35%
5.88
15.90%
4.15
29.40%
stock based compensation to revenue
tangible asset value
111K
-
2.28M
1,956.76%
195.98M
8,484.41%
124.00M
36.73%
162.30M
30.88%
136.15M
16.12%
tangible book value per share
0.00
-
0.08
1,956.76%
13.83
16,191.21%
5.07
63.35%
5.88
15.90%
4.15
29.40%
working capital
111K
-
2.27M
1,944.14%
195.43M
8,513.22%
121.59M
37.78%
159.15M
30.89%
132.80M
16.56%

All numbers in USD (except ratios and percentages)